Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HanBio Biotechnology
Shanghai, Shanghai, Chinahanbiology.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Hanbio is a leading provider of viral vector packaging and gene delivery solutions widely used in molecular biology and gene therapy research. Its products are cited in nearly 10,000 scientific journals. The company’s therapeutic arm has three bispecific antibodies at IND/preclinical stage targeting cancers with high prevalence in China.
- Therapeutic areas
- OtherOncology
- Modalities
- Viral vectorPlasmid DNACRISPR-based therapyAntibodyBispecific monoclonal antibodyRecombinant protein
- Industry
- Biotech
02
Partnerships
OrbiMedHankang CapitalSunshine Guojian Pharmaceutical
Beyond the preview
Go deeper on HanBio Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HanBio Biotechnology.